OOIR: Observatory of International Research

Papers

(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	380
Role of N7-methylguanosine in gastrointestinal tumors: Molecular mechanisms and therapeutic targets	239
Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities	155
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	145
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	141
Targeted drug delivery systems in Lymphoma treatment: Advances and clinical perspectives	95
The bridging role of neutrophils in the progression of inflammation-induced colorectal cancer	90
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	84
Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy	83
The role of protein glycosylation in colorectal cancer: From molecular pathways to clinical applications	81
Uveal melanoma modeling in mice and zebrafish	79
Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies	78
Advances in epigenetic modifications and cervical cancer research	74
Nutrition and dietary restrictions in cancer prevention	72
ESR1 activating mutations: From structure to clinical application	70
Yin yang 1: a potential regulator of immune related diseases and cancer immunity	68
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	68
Fascin-1 in primary liver cancers, perspectives for targeted therapy	68
In what area of biology has a “new” type of cell death been discovered?	65
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	63
Detection methods for mitochondrial DNA heteroplasmy and their potential single-cell applications in cancer	62
S100A8 and S100A9 in Cancer	61
Biomarkers in high grade serous ovarian cancer	59
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	56
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	56

Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	53
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance	53
Advances and prospects of mRNA vaccines in cancer immunotherapy	53
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	52
Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope	51
Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights	51
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	49
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	49
Evolution of the MUC1 gene in eutherian mammals as an adaptation responsible for the increasing incidence of cancer in humans	49
Revisiting CHK1 and WEE1 kinases as therapeutic targets in cancer	48
Targeting lipid metabolism in cancer metastasis	48
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance	47
Inhibition of nucleotide excision repair proteins associated with cancer chemotherapy	46
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	46
Integrating multi-omics proteomic approaches in deciphering the tumor microenvironment and therapeutic resistance mechanisms in prostate cancer	44
Emerging perspectives on metabolic reprogramming in the microenvironment of ovarian cancer metastasis	40
Targeting Cdc20 for cancer therapy	40
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	40